Literature DB >> 34797501

Spinal Microglia and Astrocytes: Two Key Players in Chronic Visceral Pain Pathogenesis.

Jun-Yi Long1,2, Xue-Jun Wang1,2, Xiao-Ying Li1,2, Xie-He Kong1,2, Guang Yang1,2, Dan Zhang1,2, Yan-Ting Yang1,2, Zheng Shi1,2, Xiao-Peng Ma3,4.   

Abstract

Chronic visceral pain (CVP) is one of the common symptoms of many diseases triggered by underlying diseases of the internal organs of the human body. Its causes include vascular mechanisms, mechanical factors, persistent inflammation, and unexplained functional mechanisms. Although the pathogenesis is unclear, more and more research has begun to shift from the neuronal aspect to the glial cells in recent years. Some data highlight that the spinal glial cells, particularly the microglia and astrocytes, play an essential role in CVP. Based on this, we highlight the mechanisms of microglia and astrocytes in CVP concerning the release of cytokines, chemokines, and neuroactive substances and alterations in intracellular signaling pathways during the process. Finally, because CVP is widespread in various diseases, we present future perspectives targeting microglia and astrocytes for treatment.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Astrocytes; Chronic visceral pain; Microglia; Pathogenesis; Spinal dorsal horn

Mesh:

Year:  2021        PMID: 34797501     DOI: 10.1007/s11064-021-03486-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  50 in total

Review 1.  Opioid Analgesics Adverse Effects: The Other Side of the Coin.

Authors:  Sebastiano Mercadante
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

Review 2.  The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain.

Authors:  Qasim Aziz; Maria Adele Giamberardino; Antonia Barke; Beatrice Korwisi; Andrew P Baranowski; Ursula Wesselmann; Winfried Rief; Rolf-Detlef Treede
Journal:  Pain       Date:  2019-01       Impact factor: 6.961

3.  Quantifying the Epidemic of Prescription Opioid Overdose Deaths.

Authors:  Puja Seth; Rose A Rudd; Rita K Noonan; Tamara M Haegerich
Journal:  Am J Public Health       Date:  2018-04       Impact factor: 9.308

Review 4.  Irritable bowel syndrome: a clinical review.

Authors:  William D Chey; Jacob Kurlander; Shanti Eswaran
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

5.  Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.

Authors:  David L Murphy; Jacob A Lebin; Stevan G Severtson; Heather A Olsen; Nabarun Dasgupta; Richard C Dart
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

Review 6.  Critical evaluation of animal models of visceral pain for therapeutics development: A focus on irritable bowel syndrome.

Authors:  Anthony C Johnson; Adam D Farmer; Timothy J Ness; Beverley Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2019-12-13       Impact factor: 3.598

Review 7.  Visceral Pain.

Authors:  Luke Grundy; Andelain Erickson; Stuart M Brierley
Journal:  Annu Rev Physiol       Date:  2018-10-31       Impact factor: 19.318

Review 8.  Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11).

Authors:  Rolf-Detlef Treede; Winfried Rief; Antonia Barke; Qasim Aziz; Michael I Bennett; Rafael Benoliel; Milton Cohen; Stefan Evers; Nanna B Finnerup; Michael B First; Maria Adele Giamberardino; Stein Kaasa; Beatrice Korwisi; Eva Kosek; Patricia Lavand'homme; Michael Nicholas; Serge Perrot; Joachim Scholz; Stephan Schug; Blair H Smith; Peter Svensson; Johan W S Vlaeyen; Shuu-Jiun Wang
Journal:  Pain       Date:  2019-01       Impact factor: 6.961

9.  Dynamics of oligodendrocyte generation in multiple sclerosis.

Authors:  Maggie S Y Yeung; Mehdi Djelloul; Embla Steiner; Samuel Bernard; Mehran Salehpour; Göran Possnert; Lou Brundin; Jonas Frisén
Journal:  Nature       Date:  2019-01-23       Impact factor: 49.962

10.  Altered human oligodendrocyte heterogeneity in multiple sclerosis.

Authors:  Sarah Jäkel; Eneritz Agirre; Dheeraj Malhotra; Charles Ffrench-Constant; Anna Williams; Gonçalo Castelo-Branco; Ana Mendanha Falcão; David van Bruggen; Ka Wai Lee; Irene Knuesel
Journal:  Nature       Date:  2019-01-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.